TrialCancer reports (Hoboken, N.J.)2022

Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.

Joël Guigay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.